Mechanisms of disease: Mendelian disorders of membrane trafficking

New England Journal of Medicine

Volumn 365, Issue 10, 2011, Pages 927-938

  De Matteis, Maria Antonietta ^a,c   Luini, Alberto ^a,b  

^a TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

^b INSTITUTE OF PROTEIN BIOCHEMISTRY   (Italy)

^c Consorzio Mario Negri Sud ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COAT PROTEIN COMPLEX I; COAT PROTEIN COMPLEX II; SOMATOMEDIN B RECEPTOR; MEMBRANE PROTEIN;

CELL MEMBRANE; CYSTIC FIBROSIS; DENT DISEASE; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; ENDOSOME; FANCONI RENOTUBULAR SYNDROME; GENE MUTATION; GENETIC DISORDER; GOLGI COMPLEX; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; LOWE SYNDROME; LYSOSOME; MEMBRANE TRANSPORT; PRIORITY JOURNAL; REVIEW; SECRETORY GRANULE; SYNAPSE VESICLE; TRANS GOLGI NETWORK; UNFOLDED PROTEIN RESPONSE; GENETICS; METABOLISM; MUTATION; PHYSIOLOGY; PROTEIN TRANSPORT; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; CELL MEMBRANE; GENETIC DISEASES, INBORN; HUMANS; MEMBRANE PROTEINS; MUTATION; PROTEIN TRANSPORT;

EID: 80052592689     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMra0910494     Document Type: Review

References (54)

1. Gilchrist A., Au C.E., Hiding J., et al. Quantitative proteomics analysis of the secretory pathway. Cell 2006;127:1265-1281 (Pubitemid 44914006)
2. Mellman I., Warren G. The road taken: Past and future foundations of membrane traffic. Cell 2000;100:99-112. (Pubitemid 30046299)
3. Schekman R. SEC mutants and the secretory apparatus. Nat Med 2002;8:1055-1058 (Pubitemid 35175950)
4. Rothman J.E. The machinery and principles of vesicle transport in the cell. Nat Med 2002;8:1059-1062 (Pubitemid 35175951)
5. Ellgaard L., Helenius A. Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol 2003;4:181-191 (Pubitemid 36288040)
6. Vembar S.S., Brodsky J.L. One step at a time: Endoplasmic-reticulum- associated degradation. Nat Rev Mol Cell Biol 2008;9: 944-957
7. Ron D., Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007;8:519-529 (Pubitemid 46985379)
8. Watson P., Stephens DJ. ER-to-Golgi transport: form and formation of vesicular and tubular carriers. Biochim Biophys Acta 2005;1744:304-15.
9. Béthune J., Wieland F., Moelleken J. COPI-mediated transport. J Membr Biol 2006;211:65-79. (Pubitemid 44653051)
10. Allan V.J., Schroer T.A. Membrane motors. Curr Opin Cell Biol 1999;11:476-482 (Pubitemid 29396794)
11. Hirokawa N., Noda Y., Tanaka Y., Niwa S. Kinesin superfamily motor proteins and intracellular transport. Nat Rev Mol Cell Biol 2009;10:682-696
12. Glick B.S., Nakano A. Membrane trafficwithin the Golgi apparatus. Annu Rev Cell Dev Biol 2009;25:113-132
13. Rink J., Ghigo E., Kalaidzidis Y., Zerial M. Rab conversion as a mechanism of progression from early to late endosomes. Cell 2005;122:735-749 (Pubitemid 41242638)
14. Bonfanti L., Mironov A.A. Jr, Martínez-Menárguez J.A., et al. Procollagen traverses the Golgi stack without leaving the lumen of cisternae: Evidence for cisternal maturation. Cell 1998;95:993-1003. (Pubitemid 29019051)
15. Desjardins M., Griffiths G. Phagocytosis: Latex leads the way. Curr Opin Cell Biol 2003;15:498-503. (Pubitemid 36928054)
16. Luzio J.P., Pryor P.R., Bright N.A. Lysosomes: Fusion and function. Nat Rev Mol Cell Biol 2007;8:622-632 (Pubitemid 47106614)
17. Rizzoli S.O., Jahn R. Kiss-and-run, collapse and 'readily retrievable' vesicles. Traffic 2007;8:1137-1144 (Pubitemid 47244870)
18. Duclos S., Diez R., Garin J., et al. Rab5 regulates the kiss and run fusion between phagosomes and endosomes and the acquisition of phagosome leishmanicidal properties in RAW 264.7 macrophages. J Cell Sci 2000;113:3531-3541
19. Trucco A., Polishchuk R.S., Martella O., et al. Secretory traffic triggers the formation of tubular continuities across Golgi subcompartments. Nat Cell Biol 2004;6:1071-1081 (Pubitemid 39468008)
20. De Matteis M.A., Luini A. Exiting the Golgi complex. Nat Rev Mol Cell Biol 2008;9:273-284 (Pubitemid 351430855)
21. Braulke T., Bonifacino JS. Sorting of lysosomal proteins. Biochim Biophys Acta 2009;1793:605-14.
22. Blackstone C., O'Kane C.J., Reid E. Hereditary spastic paraplegias: Membrane traffic and the motor pathway. Nat Rev Neurosci 2011;12:31-42. [Erratum, Nat Rev Neurosci 2011;12:118.]
23. Hanson P.I., Shim S., Merrill S.A. Cell biology of the ESCRT machinery. Curr Opin Cell Biol 2009;21:568-574
24. Lenz M., Morlot S., Roux A. Mechanical requirements for membrane fission: Common facts from various examples. FEBS Lett 2009;583:3839-3846
25. Loubéry S., Coudrier E. Myosins in the secretory pathway: Tethers or transporters? Cell Mol Life Sci 2008;65:2790-2800
26. Lupashin V., Sztul E. Golgi tethering factors. Biochim Biophys Acta 2005;1744: 325-39.
27. Südhof T.C., Rothman J.E. Membrane fusion: Grappling with SNARE and SM proteins. Science 2009;323:474-477
28. Doherty G.J., McMahon H.T. Mechanisms of endocytosis. Annu Rev Biochem 2009;78:857-902.
29. Pryor P.R., Luzio JP. Delivery of endocytosed membrane proteins to the lysosome. Biochim Biophys Acta 2009;1793: 615-24.
30. Mizushima N., Levine B., Cuervo A.M., Klionsky D.J. Autophagy fights disease through cellular self-digestion. Nature 2008;451:1069-1075 (Pubitemid 351317450)
31. Russell M.R., Nickerson D.P., Odorizzi G. Molecular mechanisms of late endosome morphology, identity and sorting. Curr Opin Cell Biol 2006;18:422-428 (Pubitemid 44040964)
32. Nickel W., Rabouille C. Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol 2009;10:148-155[Erratum, Nat Rev Mol Cell Biol 2009; 10:234.]
33. Pulvirenti T., Giannotta M., Capestrano M., et al. A traffic-activated Golgi-based signalling circuit coordinates the secretory pathway. Nat Cell Biol 2008;10:912-922
34. Winter E.E., Goodstadt L., Ponting C.P. Elevated rates of protein secretion, evolution, and disease among tissue-specific genes. Genome Res 2004;14:54-61. (Pubitemid 38088525)
35. Rowe S.M., Miller S., Sorscher E.J. Cystic fibrosis. N Engl J Med 2005;352:1992-2001. (Pubitemid 40638370)
36. Lin W., Popko B. Endoplasmic reticulum stress in disorders of myelinating cells. Nat Neurosci 2009;12:379-385
37. Dowling J.J., Gibbs E.M., Feldman E.L. Membrane traffic and muscle: Lessons from human disease. Traffic 2008;9:1035-1043 (Pubitemid 351916880)
38. Boyadjiev S.A., Fromme J.C., Ben J., et al. Cranio-lenticulo-sutural dysplasia is caused by a SEC23A mutation leading to abnormal endoplasmic-reticulum-to-Golgi trafficking. Nat Genet 2006;38:1192-1197 (Pubitemid 44470366)
39. Gedeon A.K., Colley A., Jamieson R., et al. Identification of the gene (SEDL) causing X-linked spondyloepiphyseal dysplasia tarda. Nat Genet 1999;22:400-404 (Pubitemid 29369535)
40. Jones B., Jones E.L., Bonney S.A., et al.Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders. Nat Genet 2003;34:29-31. (Pubitemid 36548786)
41. Nichols W.C., Seligsohn U., Zivelin A., et al. Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII. Cell 1998;93:61-70. (Pubitemid 28173552)
42. Hickman S., Neufeld E.F. A hypothesis for I-cell disease: Defective hydrolases that do not enter lysosomes. Biochem Biophys Res Commun 1972;49:992-999
43. Kornfeld S. Trafficking of lysosomal enzymes in normal and disease states. J Clin Invest 1986;77:1-6. (Pubitemid 16101192)
44. Salinas S., Proukakis C., Crosby A., Warner T.T. Hereditary spastic paraplegia: Clinical features and pathogenetic mechanisms. Lancet Neurol 2008;7:1127-1138
45. Shibata Y., Hu J., Kozlov M.M., Rapoport T.A. Mechanisms shaping the membranes of cellular organelles. Annu Rev Cell Dev Biol 2009;25:329-354
46. Orso G., Pendin D., Liu S., et al. Homotypic fusion of ER membranes requires the dynamin-like GTPase atlastin. Nature 2009;460:978-983[Erratum, Nature 2010; 464:942.]
47. Park S.H., Zhu P.P., Parker R.L., Blackstone C. Hereditary spastic paraplegia proteins REEP1, spastin, and atlastin-1 coordinate microtubule interactions with the tubular ER network. J Clin Invest 2010;120:1097-1110
48. Vicinanza M., D'Angelo G., Di Campli A., De Matteis M.A. Function and dysfunction of the PI system in membrane trafficking. EMBO J 2008;27:2457-2470
49. Christensen E.I., Verroust P.J., Nielsen R. Receptor-mediated endocytosis in renal proximal tubule. Pflugers Arch 2009;458: 1039-1048
50. Picollo A., Pusch M. Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5. Nature 2005;436: 420-423 (Pubitemid 41059054)
51. Hichri H., Rendu J., Monnier N., et al. From Lowe syndrome to Dent disease: Correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes. Hum Mutat 2011;32:379-388
52. Brinkman R.R., Dubé M.P., Rouleau G.A., Orr A.C., Samuels M.E. Human monogenic disorders - A source of novel drug targets. Nat Rev Genet 2006;7:249-260
53. Fishman M.C., Porter J.A. A new grammar for drug discovery. Nature 2005;437: 491-493
54. Jones A.M., Helm J.M. Emerging treatments in cystic fibrosis. Drugs 2009;69: 1903-1910